US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Apnimed

18.22

+0.18001.00%

Post-market: 18.220.00000.00%19:30 EDT

Volume:332.03K

Turnover:6.05M

Market Cap:758.51M

PE:4.67

High:18.61

Open:18.05

Low:17.38

Close:18.04

52wk High:35.29

52wk Low:16.12

Shares:41.63M

Float Shares:12.00M

Volume Ratio:0.59

T/O Rate:2.77%

Dividend:- -

Dividend Rate:- -

EPS(TTM):3.90

EPS(LYR):-23.7581

ROE:--

ROA:-36.94%

PB:-4.31

PE(LYR):-0.77

Loading ...

Overview Company News Filings

Apnimed, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Apnimed: Buy Rating Reiterated on Strong Oxnimbi OSA Profile and Unchanged $50 Price Target

Apnimed Q2 Swings to Earnings, Revenue Declines

MT Newswires Live

Apnimed Q2 EPS $3.91 Beats $(0.34) Estimate, Sales $12.080M

Benzinga Earnings

Apnimed Q2 FY26 Net Income Swings to USD 125.94 Million; Revenue Falls 29.38% to USD 12.08 Million

Apnimed Reports Second Quarter 2026 Financial Results and Provides Corporate Update

THOMSON REUTERS

Apnimed Grants Inducement Stock Options for 428,428 Shares at USD 26.85 Each

Apnimed, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS

Apnimed, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

U.S. Small Caps Drop; Apnimed Posts Biggest Loss

Apnimed, Inc. : Bofa Global Research Initiates Coverage with Buy Rating and Price Objective $41.00

THOMSON REUTERS

Apnimed Initiated at Buy by B of a Securities

LifeSci Capital Initiates Apnimed at Outperform With $50 Price Target

MT Newswires Live

Apnimed initiated with an Overweight at Cantor Fitzgerald

Apnimed initiated with an Outperform at LifeSci Capital

Apnimed initiated with a Buy at BofA

U.S. Research Roundup-Masco, Sherwin-Williams, Vulcan Materials

Morningside Venture Investments Reports Apnimed Common Share Acquisition Valued at $5 Million

Insider Move: Apnimed Director Makes Bold New Investment

Apnimed IPO Raises $220.8 Million at $16 Per Share

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/stock/APMD/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"APMD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"APMD\",,,,,undefined,":{"symbol":"APMD","market":"US","secType":"STK","nameCN":"Apnimed","latestPrice":18.22,"timestamp":1791489600000,"preClose":18.04,"halted":0,"volume":332025,"hourTrading":{"tag":"盘后","latestPrice":18.22,"preClose":18.22,"latestTime":"19:30 EDT","volume":3622,"amount":66001.08,"timestamp":1791502204179,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.009977827050997767,"floatShares":12000000,"shares":41630779,"eps":3.898,"marketStatus":"Closed","change":0.18,"latestTime":"10-08 16:00:00 EDT","open":18.05,"high":18.61,"low":17.375,"amount":6054079.769175,"amplitude":0.068459,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":3.898,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791532800000},"marketStatusCode":5,"adr":0,"listingDate":1785470400000,"exchange":"NASDAQ","adjPreClose":18.04,"preHourTrading":{"tag":"盘前","latestPrice":18.03,"preClose":18.04,"latestTime":"09:29 EDT","volume":906,"amount":16336.141266,"timestamp":1791466199999,"change":-0.01,"changeRate":-0.000554,"amplitude":0.018293},"postHourTrading":{"tag":"盘后","latestPrice":18.22,"preClose":18.22,"latestTime":"19:30 EDT","volume":3622,"amount":66001.08,"timestamp":1791502204179,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.589352},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"APMD\",,,,,undefined,":{"symbol":"APMD","floatShares":12000000,"roa":"-36.94%","roe":"--","lyrEps":-23.758134,"volumeRatio":0.589352,"shares":41630779,"dividePrice":0,"high":18.61,"amplitude":0.068459,"preClose":18.04,"low":17.375,"week52Low":16.12,"pbRate":"-4.31","psRate":"6.59","week52High":35.29,"institutionHeld":0,"latestPrice":18.22,"eps":3.898,"divideRate":0,"volume":332025,"delay":0,"ttmEps":3.898,"open":18.05,"prevYearClose":16,"prevWeekClose":21.51,"prevMonthClose":21.91,"prevQuarterClose":21.91,"fiveDayClose":22.54,"twentyDayClose":26.8,"sixtyDayClose":16},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/APMD\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"APMD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"APMD\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.75,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.75,"analysts":4,"updateTime":1787716800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/APMD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"APMD","date":"2026-10-07","current":4.674192,"percent":0.630435,"low":-12.845073,"twenty":-11.861048,"median":-8.277404,"eighty":5.733734,"high":7.380306,"avg":-4.048979,"sd":8.119888,"marketCap":776414028},"quantilePoints":[{"date":"2026-08-07","current":-8.661063,"twenty":-8.320585,"median":-7.986942,"eighty":-7.766377,"marketCap":1110270342},{"date":"2026-08-14","current":-8.943759,"twenty":-8.664791,"median":-8.256435,"eighty":-7.766377,"marketCap":1146509438},{"date":"2026-08-21","current":-12.343549,"twenty":-9.895607,"median":-8.661063,"eighty":-7.942829,"marketCap":1582331874},{"date":"2026-08-28","current":-12.417048,"twenty":-11.890448,"median":-9.403529,"eighty":-8.185761,"marketCap":1591753815},{"date":"2026-09-04","current":-12.023611,"twenty":-12.049552,"median":-9.950282,"eighty":-8.269016,"marketCap":1541318719},{"date":"2026-09-11","current":-8.703457,"twenty":-12.127375,"median":-10.111822,"eighty":-8.343574,"marketCap":1115704877},{"date":"2026-09-18","current":7.153807,"twenty":-12.066846,"median":-9.872618,"eighty":-7.766377,"marketCap":1170241197},{"date":"2026-09-25","current":5.50469,"twenty":-12.02707,"median":-8.703457,"eighty":6.030983,"marketCap":900473749},{"date":"2026-10-02","current":5.736279,"twenty":-11.930224,"median":-8.524375,"eighty":5.874723,"marketCap":938357758},{"date":"2026-10-07","current":4.7463,"twenty":-11.861048,"median":-8.277404,"eighty":5.733734,"marketCap":776414028}],"updateTime":1791507915654},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"APMD\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672749999","title":"Apnimed, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2672749999","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672749999?lang=en_us&edition=fundamental","pubTime":"2026-10-03 04:05","pubTimestamp":1790971500,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., Oct.  02, 2026 (GLOBE NEWSWIRE) -- Apnimed, Inc. (Nasdaq: APMD) (“Apnimed” or the “Company”), a late-stage clinical pharmaceutical company dedicated to the discovery, development and","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/02/3374015/0/en/apnimed-inc-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LCLG","BK4007","APMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666499535","title":"Apnimed: Buy Rating Reiterated on Strong Oxnimbi OSA Profile and Unchanged $50 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2666499535","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666499535?lang=en_us&edition=fundamental","pubTime":"2026-09-09 21:15","pubTimestamp":1788959740,"startTime":"0","endTime":"0","summary":"LifeSci Capital analyst Francois Brisebois maintained a Buy rating on Apnimed, Inc. today and set a price target of $50.00. Francois Brisebois has ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/apnimed-buy-rating-reiterated-on-strong-oxnimbi-osa-profile-and-unchanged-50-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/apnimed-buy-rating-reiterated-on-strong-oxnimbi-osa-profile-and-unchanged-50-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["APMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666370831","title":"Apnimed Q2 Swings to Earnings, Revenue Declines","url":"https://stock-news.laohu8.com/highlight/detail?id=2666370831","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666370831?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:52","pubTimestamp":1788900776,"startTime":"0","endTime":"0","summary":"Apnimed (APMD) reported Q2 earnings late Tuesday of $3.91 per diluted share, swinging from a loss of $14.61 a year earlier.Three analysts polled by FactSet expected a loss of $0.49.Revenue for the three months ended June 30 was $12.1 million, down from $17.1 million a year earlier.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["APMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666437773","title":"Apnimed Q2 EPS $3.91 Beats $(0.34) Estimate, Sales $12.080M","url":"https://stock-news.laohu8.com/highlight/detail?id=2666437773","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666437773?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:41","pubTimestamp":1788900101,"startTime":"0","endTime":"0","summary":"Apnimed (NASDAQ:APMD) reported quarterly earnings of $3.91 per share which beat the analyst consensus estimate of $(0.34) by 1250 percent.  The company reported $12.080 million in sales this quarter.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/09/61673753/apnimed-q2-eps-3-91-beats-0-34-estimate-sales-12-080m","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"Apnimed Q2 EPS $3.91 Beats $(0.34) Estimate, Sales $12.080M","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666377219","title":"Apnimed Q2 FY26 Net Income Swings to USD 125.94 Million; Revenue Falls 29.38% to USD 12.08 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2666377219","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666377219?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:39","pubTimestamp":1788899985,"startTime":"0","endTime":"0","summary":"Apnimed Q2 FY26 net income swings to USD 125.94 million; revenue falls 29.38% to USD 12.08 millionApnimed swung to net income of $125.94 million in Q2 2026 from a net loss a year earlier.Revenue fell ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDLbHmTvj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCDF","BK4585","IE00B64PRP62.GBP","IE00BN0W2T93.GBP","IE00BQXX3D17.EUR","APMD","IE00BN0W2W23.USD","IE00BKPKM429.USD","SG9999014005.SGD","SG9999014021.USD","BK4588","LU2210150020.SGD","BK4007","BK4112","IE00BQXX3C00.GBP","NDAQ","LU0314104364.USD","SG9999014013.SGD","IE00BQXX3F31.USD","SG9999014039.USD","IE00BGHQF748.EUR","LU2210149790.SGD","IE00B3QW5Z07.USD","LU2095319765.USD","IE00BN0W2V16.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666377262","title":"Apnimed Reports Second Quarter 2026 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2666377262","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666377262?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:39","pubTimestamp":1788899952,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUA6RNRTF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["APMD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665591073","title":"Apnimed Grants Inducement Stock Options for 428,428 Shares at USD 26.85 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2665591073","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665591073?lang=en_us&edition=fundamental","pubTime":"2026-09-05 04:01","pubTimestamp":1788552077,"startTime":"0","endTime":"0","summary":"Apnimed grants inducement stock options for 428,428 shares at USD 26.85 eachApnimed granted non-qualified stock options covering 428,428 shares to 10 new non-executive employees under its 2026 Inducem","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nNDL4P3wVZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","IE00B64PRP62.GBP","LU2095319765.USD","IE00BQXX3C00.GBP","IE00BKPKM429.USD","IE00BN0W2V16.EUR","BK4585","IE00BQXX3D17.EUR","BCDF","SG9999014039.USD","BK4588","SG9999014005.SGD","BK4112","BK4007","NDAQ","SG9999014013.SGD","LU0314104364.USD","IE00BN0W2W23.USD","SG9999014021.USD","LU2210149790.SGD","IE00BQXX3F31.USD","APMD","IE00BN0W2T93.GBP","IE00B3QW5Z07.USD","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665359120","title":"Apnimed, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2665359120","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665359120?lang=en_us&edition=fundamental","pubTime":"2026-09-05 04:01","pubTimestamp":1788552060,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nTUA6DBLRJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","APMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665351458","title":"Apnimed, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2665351458","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665351458?lang=en_us&edition=fundamental","pubTime":"2026-09-05 04:01","pubTimestamp":1788552060,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., Sept.  04, 2026 (GLOBE NEWSWIRE) -- Apnimed, Inc. (Nasdaq: APMD) (“Apnimed” or the “Company”), a late stage clinical pharmaceutical company dedicated to the discovery, development an","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/04/3356773/0/en/apnimed-inc-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LCLG","APMD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664833358","title":"U.S. Small Caps Drop; Apnimed Posts Biggest Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2664833358","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664833358?lang=en_us&edition=fundamental","pubTime":"2026-09-01 04:20","pubTimestamp":1788207600,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of small-cap companies fell Monday, as the Russell 2000 Index dropped 0.5%, and the S&P Small Cap 600 Index was down 0.7%.Among companies with a market value of $1 billion to $6.7 billion, Apnimed Inc. was the biggest laggard during the session, dropping 12%, followed by shares of Herbalife Ltd., which dropped 12%. Shares of Lindblad Expeditions Holdings Inc. dropped 10%, Falcon's Beyond Global Inc. shares plunged 9.4%, and Latigo Biotherapeutics Inc. plunged 9.1%.Evolution Metals & Technologies Corp. was the best performer, surging 18%, followed by Standard Nuclear Inc., which jumped 14%. Strive Inc. Cl A shares surged 11%, Obsidian Therapeutics Inc. jumped 7.4%, and shares of Avis Budget Group Inc. surged 6.8%.Major stock indexes in the U.S. fell Monday with the Nasdaq Composite Index declining 0.1%. Meanwhile, the S&P 500 Index declined 0.3%, and the Dow Jones Industrial Average declined 0.7%.Data source: Dow","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","APMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662173932","title":"Apnimed, Inc. : Bofa Global Research Initiates Coverage with Buy Rating and Price Objective $41.00","url":"https://stock-news.laohu8.com/highlight/detail?id=2662173932","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662173932?lang=en_us&edition=fundamental","pubTime":"2026-08-25 19:10","pubTimestamp":1787656244,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nAZN4TG5UR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["APMD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662736246","title":"Apnimed Initiated at Buy by B of a Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2662736246","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662736246?lang=en_us&edition=fundamental","pubTime":"2026-08-25 18:59","pubTimestamp":1787655540,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/APMD/analyst-ratings","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","APMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662273683","title":"LifeSci Capital Initiates Apnimed at Outperform With $50 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2662273683","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662273683?lang=en_us&edition=fundamental","pubTime":"2026-08-25 18:46","pubTimestamp":1787654763,"startTime":"0","endTime":"0","summary":"LifeSci Capital Initiates Apnimed at Outperform With $50 Price Target","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["APMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662735746","title":"Apnimed initiated with an Overweight at Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2662735746","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662735746?lang=en_us&edition=fundamental","pubTime":"2026-08-25 18:35","pubTimestamp":1787654119,"startTime":"0","endTime":"0","summary":"Cantor Fitzgerald initiated coverage of Apnimed (APMD) with an Overweight rating and $60 price target Published first on TheFly – the ultimate sour...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/apnimed-initiated-with-an-overweight-at-cantor-fitzgerald-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/apnimed-initiated-with-an-overweight-at-cantor-fitzgerald-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["APMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662735898","title":"Apnimed initiated with an Outperform at LifeSci Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2662735898","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662735898?lang=en_us&edition=fundamental","pubTime":"2026-08-25 18:20","pubTimestamp":1787653215,"startTime":"0","endTime":"0","summary":"LifeSci Capital analyst Francois Brisebois initiated coverage of Apnimed (APMD) with an Outperform rating and $50 price target Published first on T...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/apnimed-initiated-with-an-outperform-at-lifesci-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/apnimed-initiated-with-an-outperform-at-lifesci-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["APMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662358957","title":"Apnimed initiated with a Buy at BofA","url":"https://stock-news.laohu8.com/highlight/detail?id=2662358957","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662358957?lang=en_us&edition=fundamental","pubTime":"2026-08-25 18:15","pubTimestamp":1787652909,"startTime":"0","endTime":"0","summary":"BofA analyst Jason Gerberry initiated coverage of Apnimed (APMD) with a Buy rating and $41 price target Sole asset Oxnimbi, an oral therapy for obs...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/apnimed-initiated-with-a-buy-at-bofa-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/apnimed-initiated-with-a-buy-at-bofa-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","APMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662781491","title":"U.S. Research Roundup-Masco, Sherwin-Williams, Vulcan Materials","url":"https://stock-news.laohu8.com/highlight/detail?id=2662781491","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662781491?lang=en_us&edition=fundamental","pubTime":"2026-08-25 15:27","pubTimestamp":1787642845,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Masco, Sherwin-Williams, Vulcan MaterialsAug 25 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including Masco","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nL8N44M0AY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FIVE","APMD","SHW","FAC","MRVL","PTF","MRSH","ALB","CHYM","CLMT","MAS","WMS","GPN","GTEK","FMC","FIS","HON","TEK","AMRZ","CSL","JBTM","MLM","EXP","VMC","LEU","MU","SMHX","DNLI","ANAB","CLSE","KNF","DT","DAMD","AWI","KRO","INSM","ACAD","EMSF","KDK","AMD","BKR","CURB","GTLB","AMAT","FBIN","BXP","LRCX","ACM","FLNC","IETC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657679578","title":"Morningside Venture Investments Reports Apnimed Common Share Acquisition Valued at $5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657679578","media":"Reuters","labels":["insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657679578?lang=en_us&edition=fundamental","pubTime":"2026-08-06 04:20","pubTimestamp":1785961207,"startTime":"0","endTime":"0","summary":"Morningside Venture Investments reports Apnimed common share acquisition valued at $5 millionMorningside Venture Investments, a 10% owner of Apnimed, converted holdings into 6,840,213 shares of common","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nNDL6MXLgv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Morningside Venture Investments Reports Apnimed Common Share Acquisition Valued at $5 Million","news_tag":"insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656713586","title":"Insider Move: Apnimed Director Makes Bold New Investment","url":"https://stock-news.laohu8.com/highlight/detail?id=2656713586","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656713586?lang=en_us&edition=fundamental","pubTime":"2026-08-04 10:08","pubTimestamp":1785809300,"startTime":"0","endTime":"0","summary":"New insider activity at Apnimed, Inc. ( ($APMD) ) has taken place on August 3, 2026. Director Paul Sekhri of Apnimed, Inc. has significantly increa...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/insider-move-apnimed-director-makes-bold-new-investment-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/insider-move-apnimed-director-makes-bold-new-investment-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["APMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656025303","title":"Apnimed IPO Raises $220.8 Million at $16 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2656025303","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656025303?lang=en_us&edition=fundamental","pubTime":"2026-08-04 04:46","pubTimestamp":1785790016,"startTime":"0","endTime":"0","summary":"Apnimed IPO raises $220.8 million at $16 per shareApnimed closed an upsized IPO of 13,800,000 common shares at USD 16 per share.Deal size included 1,800,000 shares from the full exercise of the underw","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nNDLtt0cS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014005.SGD","BK4585","SG9999014039.USD","IE00B3QW5Z07.USD","LU2210149790.SGD","IE00BN0W2T93.GBP","LU2095319765.USD","NDAQ","BCDF","LU2210150020.SGD","BK4112","SG9999014013.SGD","IE00BKPKM429.USD","IE00BN0W2W23.USD","IE00B64PRP62.GBP","LU0314104364.USD","IE00BGHQF748.EUR","SG9999014021.USD","BK4588","APMD","IE00BN0W2V16.EUR"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":35,"code":"91000000","status":"200"}]}}